Amarin (Ireland)

Amarin (Ireland)

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Amarin (Ireland), Ireland, covering academic research published from 2005 to 2023. Read More.


Open Access Percentage

79%


Total
Publications

280


Total Open
Publications

220


Total
Citations

6.6K


Open Access
Percentage

79%


Total
Publications

280


Total Open
Publications

220


Total
Citations

6.6K

Wikipedia

Website

download

Breakdown

56% 21% 2% 21%

Publisher Open

56%

Both

21%

Other Platform Open

2%

Closed

21%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

051015202530Total Publications
2005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

14%OA Journal

OA Journal 14%

31

Hybrid 71%

152

No Guarantees 15%

32

Other Platform Open

Domain 89%

57

Institution 28%

18

Preprint 5%

3

Public 5%

3

Other Internet 5%

3

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
56
Europe PMC
Domain
27
University of California - eScholarship University of California
Institution
5
Ghent University - Ghent University Academic Bibliography
Institution
4
Semantic Scholar
Public
3
Le Centre pour la Communication Scientifique Directe - HAL - Inria
Institution
3
University of Oxford - Oxford University Research Archive (ORA)
Institution
2
University of Groningen / Centre for Information Technology - University of Groningen research database
Institution
2
University of Dundee - Discovery Research Portal
Institution
2
RePEc: Research Papers in Economics - RePEc
Preprint
2
1 / 3

Data updated 13 August 2024

Share

Share

Share